Xbrane Biopharma (Sweden) Price on January 23, 2025

Xbrane Biopharma Valuation on January 23, 2025

Xbrane Biopharma Trading Date Momentum on January 23, 2025

On January 23 2025 Xbrane Biopharma AB was traded for  0.16  at the closing time. The highest price during the trading period was 0.16  and the lowest recorded bid was listed for  0.16 . The volume for the day was 2.2 M. This history from January 23, 2025 had no short-term effect on price fluctuation. The trading price change to the current price is 0.00% .

Xbrane Biopharma Fundamentals Correlations and Trends

By evaluating Xbrane Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Xbrane Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Xbrane financial account trend analysis is a perfect complement when working with valuation or volatility modules.

Xbrane Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Xbrane is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Xbrane Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Xbrane Biopharma stock prices may prove useful in developing a viable investing in Xbrane Biopharma

Xbrane Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Market strength indicators help investors to evaluate how Xbrane Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xbrane Biopharma shares will generate the highest return on investment. By undertsting and applying Xbrane Biopharma stock market strength indicators, traders can identify Xbrane Biopharma AB entry and exit signals to maximize returns

Predictive indicators are helping investors to find signals for Xbrane Biopharma's price direction in advance. Along with the technical and fundamental analysis of Xbrane Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Xbrane to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

When running Xbrane Biopharma's price analysis, check to measure Xbrane Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xbrane Biopharma is operating at the current time. Most of Xbrane Biopharma's value examination focuses on studying past and present price action to predict the probability of Xbrane Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xbrane Biopharma's price. Additionally, you may evaluate how the addition of Xbrane Biopharma to your portfolios can decrease your overall portfolio volatility.